Chosa Oncology, Danish -Swedish biotechnology company, has developed the iCIP platform, which includes a liposomal formulation of cisplatin (LiPlaCis) and the companion diagnostic (DRP) tool detecting patients who benefits the most of the cisplatin treatment. The recently achieved clinical phase 2b results mean that the Company is now gearing up the business development activities to find partners for partnership or trade deal.

Quotes for CHOSA Oncology AB

Created with Highstock 6.0.7CloseTraded Volume24. feb3. mar10. mar17. mar24. mar31. mar7. apr14. apr28. apr5. maj12. maj19. maj0.20.40.60.81060T120T180T240T

Right Now

+/-
-0.125
%
−15,15%
Latest
0.7
High
0.7
Low
0.68
Volume
3 000
Turnover (SEK)
2 080
Market Value (MSEK)
49,7
Time (Latest trade)

Board

CEO

  • Peter Buhl

Chairperson of the Board

  • Ingrid Atteryd Heiman

Board

  • Claus Frisenberg Pedersen
  • Fred Hirsch
  • Morten Myrhøj
  • Neil Goldsmith
  • Ulla Hald Buhl

Largest Owners

Name Capital % Votes % Date
Buhl Krone Holding ApS 22,04 22,04 2025-03-27
Claus Frisenberg Pedersen 11,68 11,68 2023-01-18
IPO Nordic Fund A/S 8,36 8,36 2025-03-27
Smerud Medical Research International AS 7,48 7,48 2025-03-27
Rutger Arnhult 5,48 5,48 2025-03-27
Nels Holding Aps 4,00 4,00 2025-03-27
Lh|Lh Invest Aps 2,97 2,97 2025-03-27
Karsgaard Holding Ostervra Aps 2,36 2,36 2025-03-27
Sorgenfri Nr. 1 A/S 2,17 2,17 2025-03-27
Rq Solutions Aps 1,87 1,87 2025-03-27
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

NameTransaction DateTypeInstrumentAmountPriceValueCurrency
Peter Buhl Jensen2023-09-13Buy TransactionCHOSA Oncology 100 7870,770 550,9SEK
Buhl Krone Holding ApS2023-01-18en-USCHOSA Oncology 15 506 9351,0516 282 281,8SEK
Arrow Strategy Holding 2 Aps2023-01-18en-USCHOSA Oncology 7 332 9521,057 699 599,6SEK
Buhl Krone Holding ApS2023-01-18en-USCHOSA Oncology 15 506 9351,0516 282 281,8SEK
Anders Ljungqvist2022-03-28Sell TransactionRHOVAC BTU- 1 327 5250,02−26 550,5SEK
Rq Solutions Aps2021-12-14Sell TransactionCHOSA Oncology- 112 70025,43−2 865 961,0SEK
Aleksandra Waldenström Ellervik2021-05-19en-USTeckningsoption 2021/2024 50 0000,9748 500,0SEK
Aleksandra Waldenström Ellervik2021-05-19Sell TransactionTeckningsoption 2019/2022- 50 0000,5−25 000,0SEK
Henrik Stage2021-05-19Sell TransactionTeckningsoption 2019/2022- 250 0000,5−125 000,0SEK
Henrik Stage2021-05-19en-USTeckningsoption 2021/2024 250 0000,97242 500,0SEK
Steffen Wad Jørgensen2021-05-19Sell TransactionTeckningsoption 2020/2022- 200 0000,5−100 000,0SEK
Anders Månsson2021-05-19Buy TransactionTeckningsoption 2021/2024 350 0000,97339 500,0SEK
Anders Månsson2021-05-19Sell TransactionTeckningsoption 2019/2022- 350 0000,5−175 000,0SEK
Steffen Wad Jørgensen2021-05-19en-USCHOSA Oncology 200 0000,97194 000,0SEK
Lars Höckenström2020-12-11Buy TransactionCHOSA Oncology 2 30024,3455 982,0SEK
Anders Månsson2020-12-04Buy TransactionCHOSA Oncology 2 26420,9347 385,5SEK
Steffen Wad Jorgensen2020-05-12en-USCHOSA Oncology 200 0000,0714 000,0SEK
Anders Månsson2020-03-12Buy TransactionCHOSA Oncology 5 0009,849 000,0SEK
Rq Solutions Aps2019-09-30en-US2019/2022 250 0000,47117 500,0SEK
Anders Månsson2019-09-30Buy TransactionTeckningsoptioner 2019/2022 350 0000,47164 500,0SEK
Henrik Stage2019-06-19Buy TransactionCHOSA Oncology 5 55619105 564,0SEK
Anders Månsson2019-07-01Buy TransactionCHOSA Oncology 21 82019414 580,0SEK
Gunnar Gårdemyr2019-06-19Buy TransactionCHOSA Oncology 5 30019100 700,0SEK
Gunnar Gårdemyr2019-06-19Sell TransactionRhovac TR- 5 8110−0,0SEK
Mikael Ørum2019-06-19Buy TransactionCHOSA Oncology 7 40019140 600,0SEK
Rq Solutions Aps2019-06-19Buy TransactionRhoVac AB 100 000191 900 000,0SEK
Anders Månsson2019-06-19Buy TransactionCHOSA Oncology 10 00019190 000,0SEK
Cristina Glad2019-06-19Buy TransactionCHOSA Oncology 5 50019104 500,0SEK
Mikael Örum2019-06-17Sell TransactionRhoVac AB – Subscription rights- 3 71118,56−68 876,2SEK
Ventac Holding (Cyprus) Ltd2019-06-14Sell TransactionRhoVac AB TR- 1 189 4650−0,0SEK
Rq Solutions Aps2019-06-10Sell TransactionRhoVac AB- 1 240 2250−0,0SEK
Cristina Glad2018-06-01en-USRhoVac BTA 5 5001899 000,0SEK
Cristina Glad2018-05-30en-USRhovac TR 33 00000,0SEK
Lars Hedbys2018-05-30en-USRhovac TR 33 33600,0SEK
Next Stage Ventures Aps2018-06-05en-USBTA 5 55618100 008,0SEK
Next Stage Ventures Aps2018-06-05en-USSubscription rights 33 33600,0SEK
Mikael Örum2018-05-26en-USRhoVac AB New 2018 shares 11 11100,0SEK
Mikael Örum2018-06-01Buy TransactionShares 11 11118199 998,0SEK
Gunnar Gårdemyr2018-06-01en-USTR 66 66600,0SEK
Rq Solutions Aps2018-06-01Buy TransactionCHOSA Oncology 6 94318124 974,0SEK
Lars Hedbys2018-06-04Buy TransactionCHOSA Oncology 5 55618100 008,0SEK
Gunnar Gårdemyr2018-06-04en-USBTA 11 11118199 998,0SEK
Ventac Holdings Ltd.2016-12-02en-USCHOSA Oncology 11 7468,397 491,8SEK
Hans Niclas Göran Lundqvist2016-12-06en-USInlösenaktie 30 0008,3249 000,0SEK
Mads Hald Andersen2016-08-29Sell TransactionRhoVac AB shares- 20 00015,43−308 581,6SEK
Mads Hald Andersen2016-08-29Buy TransactionRhoVac AB shares 20 00016,07321 345,5SEK
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

2024-12-312024-12-312024-09-302024-06-302024-03-312023-12-312023-12-31
Number of months that the report spans 2024Q4 3 MonthsQ3 3 MonthsQ2 3 MonthsQ1 3 Months2023Q4 3 Months
Total revenue MSEK0.000.000.000.000.000.070.00
Earnings before interest and tax MSEK-9.71-4.38-1.85-1.88-1.60-23.51-2.40
Profit before tax MSEK-9.59-4.30-1.86-1.95-1.48-23.75-2.63
Net profit MSEK-9.59-4.30-1.86-1.95-1.48-23.94-2.82
Earnings per share SEK-0.000.00-0.00-0.00-0.00-0.00-0.00
Dividend per share SEK0.000.00
Equity MSEK13.8213.8217.9119.8116.4317.4117.41
Fixed assets MSEK0.000.000.000.000.000.000.00
Intangible assets MSEK9.569.5610.0810.1310.289.909.90
Current assets MSEK7.037.0310.3811.638.279.539.53
Total asset MSEK16.5916.5920.4521.7618.5419.4319.43
Long term liabilities MSEK0.000.000.000.000.000.000.00
Current liabilities MSEK2.772.772.551.952.122.022.02
Number of shares SEK70.9470.9464.8764.8764.8764.8764.87
*Compiled data from Millistream